Barclays cuts Ionis Pharmaceuticals price target to $85 from $90
Barclays cut its price target on Ionis Pharmaceuticals to $85.00 per share from $90.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.